Evotec Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Christian Wojczewski
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | less than a year |
CEO ownership | n/a |
Management average tenure | 1.7yrs |
Board average tenure | 3yrs |
Recent management updates
Recent updates
Evotec SE (ETR:EVT) Just Reported Earnings, And Analysts Cut Their Target Price
Nov 10A Piece Of The Puzzle Missing From Evotec SE's (ETR:EVT) 32% Share Price Climb
Nov 05Evotec SE (ETR:EVT) Just Reported Earnings, And Analysts Cut Their Target Price
Aug 17Evotec SE (ETR:EVT) Stock's 45% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Aug 08We Think Evotec (ETR:EVT) Has A Fair Chunk Of Debt
Aug 03Investors Aren't Entirely Convinced By Evotec SE's (ETR:EVT) Revenues
Apr 10These 4 Measures Indicate That Evotec (ETR:EVT) Is Using Debt Reasonably Well
Mar 05A Piece Of The Puzzle Missing From Evotec SE's (ETR:EVT) Share Price
Jan 09We Think Evotec (ETR:EVT) Can Stay On Top Of Its Debt
Oct 05Evotec (ETR:EVT) Has A Somewhat Strained Balance Sheet
Jun 28Is There An Opportunity With Evotec SE's (ETR:EVT) 37% Undervaluation?
May 14Does Evotec (ETR:EVT) Have A Healthy Balance Sheet?
Feb 25CEO
Christian Wojczewski (52 yo)
less than a year
Tenure
Dr. Christian Wojczewski serves as Chief Executive Officer of Evotec SE since July 01, 2024. He holds a diploma and a doctorate in chemistry from the Johann Wolfgang Goethe University in Frankfurt am Main....
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
CFO & Member of Management Board | 1.7yrs | €890.00k | 0.029% € 434.4k | |
Chief Scientific Officer & Member of Management Board | 14.3yrs | €1.48m | 0.11% € 1.6m | |
COO & Member of Management Board | 5.9yrs | €1.18m | 0.011% € 169.5k | |
Chief Executive Officer | less than a year | no data | no data | |
Chief People Officer & Member of Management Board | less than a year | no data | no data | |
Executive VP and Head of Global Investor Relations & ESG | no data | no data | no data | |
EVP Global Head of Legal & Compliance | no data | no data | no data | |
Senior VP & Head of Global Corporate Communications & Marketing | no data | no data | no data | |
Senior Vice President of Programme Management & Clinical Operations | no data | €116.00k | no data | |
Executive Vice President | no data | no data | no data | |
EVP Head of Metabolic Diseases | no data | no data | no data | |
SVP Head of Diagnostics | no data | no data | no data |
1.7yrs
Average Tenure
53yo
Average Age
Experienced Management: EVT's management team is not considered experienced ( 1.7 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Independent Vice Chairperson of the Supervisory Board | 5.5yrs | €95.00k | no data | |
Independent Chairperson of the Supervisory Board | 10.5yrs | €150.00k | no data | |
Member of the Supervisory Board | less than a year | no data | no data | |
Member of the Supervisory Board | 2.5yrs | €60.00k | no data | |
Independent Member of Supervisory Board | 3.5yrs | €85.00k | no data | |
Independent Supervisory Board | less than a year | no data | no data |
3.0yrs
Average Tenure
58yo
Average Age
Experienced Board: EVT's board of directors are considered experienced (3 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/24 01:29 |
End of Day Share Price | 2024/12/23 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Evotec SE is covered by 35 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Volker Bosse | Baader Helvea Equity Research |
Laura Lopez Pineda | Baader Helvea Equity Research |
Gerhard Schwarz | Baader Helvea Equity Research |